Mode
Text Size
Log in / Sign up
N/A N=114 Randomized Single-blind Treatment

Behavioral Treatments for Chronic Pain

Intractable Pain

Enrolled (actual)
114
Serious AEs
0.0%
Results posted
Apr 2015
Primary outcome: Primary: Brief Pain Inventory — 4.5; 5.1 units on a scale — p=.27

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Cognitive-behavioral therapy (Behavioral); Acceptance-based therapy (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
US Department of Veterans Affairs
Primary completion
Dec 2008

Outcome Measures

OutcomeResultp-value
PRIMARY
Brief Pain Inventory
4.5; 5.1 .27
SECONDARY
West Haven-Yale Multidimensional Pain Inventory - Activity Subscales
2.3; 2.0 .90
SECONDARY
SF-12
44.9; 41.0 .13
SECONDARY
Beck Depression Inventory
13.2; 17.8 .26
SECONDARY
Pain Anxiety Symptom Scale - 20
37.9; 41.5 .90

Summary

The purpose of the study is to test a brief, group-administered psychosocial intervention to reduce interference of pain with daily life, emotional distress, and pain intensity, and improve quality of life and physical activity levels in individuals with chronic pain.

Eligibility Criteria

Inclusion Criteria

  • Age 18 years old or older;
  • Proficient in English;
  • Willing and able to provide written informed consent (proposed informed consent form attached as Appendix A);
  • Diagnosis of chronic benign pain as a secondary condition associated with a primary impairment due to a traumatic injury or congenital or acquired disorder as verified by a study physician after a medical diagnostic evaluation;
  • Average pain severity rated > 4/10 with resulting functional limitations; and
  • Pain duration of at least 6 months.

Exclusion Criteria

  • Participation in psychotherapy for pain the past 2 months;
  • Serious, unstable medical illness for which inpatient hospitalization is likely over the next 3 months; and
  • The following DSM-IV diagnoses or active problems within the past 6 months noted in the patient's CPRS medical record or diagnosed during a structured psychiatric interview: 1) schizophrenia; 2) other psychotic disorder; 3) bipolar disorder; 4) organic mental disorder; 5) borderline or antisocial personality disorder; or 6) alcohol or substance abuse or dependence.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00371865). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search